June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Dysplasia and degeneration in NR2E3 retinopathy: an imaging study
Author Affiliations & Notes
  • Rola Ba-Abbad
    Department of Ophthalmology and Vision Sciences, Hospital for Sick Children, Toronto, Ontario, Canada
    Institute of Ophthalmology, University College London, London, United Kingdom
  • Ajoy Vincent
    Department of Ophthalmology and Vision Sciences, Hospital for Sick Children, Toronto, Ontario, Canada
  • Adam M Dubis
    Institute of Ophthalmology, University College London, London, United Kingdom
    National Institute for Health Research & Biomedical Research Centre, Moorfields Eye Hospital, London, United Kingdom
  • Katelyn MacNeill
    Department of Ophthalmology and Vision Sciences, Hospital for Sick Children, Toronto, Ontario, Canada
  • Elise Heon
    Department of Ophthalmology and Vision Sciences, Hospital for Sick Children, Toronto, Ontario, Canada
  • Footnotes
    Commercial Relationships   Rola Ba-Abbad, None; Ajoy Vincent, None; Adam Dubis, None; Katelyn MacNeill, None; Elise Heon, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 3224. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Rola Ba-Abbad, Ajoy Vincent, Adam M Dubis, Katelyn MacNeill, Elise Heon; Dysplasia and degeneration in NR2E3 retinopathy: an imaging study. Invest. Ophthalmol. Vis. Sci. 2017;58(8):3224.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Mutations in the nuclear receptor transcription factor NR2E3 manifest as autosomal recessive enhanced S-cone syndrome (ESCS), autosomal recessive retinitis pigmentosa (ARRP), or autosomal dominant retinitis pigmentosa (ADRP). ESCS is characterized by retinal dysplasia, degeneration, and the absence of rod photoreceptors. This retrospective, observational case series examines the retinal structure and lamination, within and outside the macula, in NR2E3 retinopathy.

Methods : Clinical examination, electroretinography (ERG), fundus color and autofluorescence (AF) images, and optical coherence tomography (OCT) scans at the macula, nasal to the disc, and anterior to the vascular arcades were examined in ten patients (age range 13–57 years) with molecularly ascertained NR2E3 retinopathy. OCT scans at the same locations were obtained from seven healthy controls.

Results : Seven patients had ESCS, one had ARRP, and two had ADRP (best corrected visual acuity 20/25–20/500). Five patients had ERG features in keeping with ESCS, and five patients had undetectable ERG. Fundus photographs showed a featureless retina in one patient with ESCS; and perimacular outer retinal atrophy with intra-retinal pigment migration in six patients with ESCS; and diffuse bone-spicule pigmentation in ARRP. Both patients with ADRP showed outer retinal atrophy with mild intra-retinal bone-spicule pigmentation. OCT scans anterior to the vascular arcades and nasal to the optic nerve head showed retinal thickening, abnormal lamination, and intra-retinal hyperreflective lesions in ESCS and ARRP. The OCT in ADRP showed relatively preserved retinal lamination with loss of the inner segment-ellipsoid zone outside of the central macula, and attenuation of the outer nuclear layer.

Conclusions : This study demonstrates the value of OCT imaging of the extramacular retina in differentiating recessive and dominant NR2E3 retinopathies. The laminar disorganization associated with recessive NR2E3 retinopathy manifests in the regions that would have normally had high rod density; whereas the relatively preserved lamination in ADRP suggests normal retinal development. The mechanistic-structural differences between the two phenotypes give an insight into the pathophysiology of these disorders, and aid in selecting candidates for novel therapies.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×